Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical ...

Since varicella is already known to be a globally distributed disease, the focus should be more on its transmissibility or disease burden. The incidence of varicella is affected by natural and ...

VULNERABILITY of involvement of the nervous system in the course of the exanthematous diseases of childhood is well known. Although the exact incidence of neurologic disorders accompanying varicella ...

The company was founded in 2013, but just began trading on the NASDAQ earlier this month. Virax specializes in the detection and treatment of viral diseases. The company recently said it is launching ...

Shares of Virax Biolabs (NASDAQ: VRAX) dropped 74% on Friday. The stock closed on Thursday at $20.80, then opened on Friday at $19.92 before climbing to its all-time high of $29 shortly before noon.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload ...

The differential diagnosis of patient with uveitis may be complex depending on the presenting clinical symptoms and signs. Based on the clinical features, both infectious and noninfectious causes ...

Boston University and Boston Medical Center researchers have recommended educational programs on vaccinations directed to gastroenterologists who prescribe immunosuppressive agents after their ...